Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Focher

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Arzneimittel-Forschung|January 1, 1985
Control of cell division by aphidicolin without adverse effects upon resting cellsS Spadari, F Focher, F Sala, et al.
Parasitology|April 17, 2009
Thymidine kinase and uridine-cytidine kinase from Entamoeba histolytica: cloning, characterization, and search for specific inhibitorsA Lossani, A Torti, S Gatti, et al.
The Biochemical Journal|January 23, 1999
L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity?A Verri, A Montecucco, G Gosselin, et al.
Journal of Medicinal Chemistry|July 13, 2000
Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesisF Focher, D Ubiali, M Pregnolato, et al.
Nucleosides & Nucleotides|August 5, 1999
Interaction of beta-L-adenosine-5'-triphosphate (L-ATP) with human deoxycytidine kinase, human DNA primase and T4 DNA ligase: does the chance direct enzymatic enantioselectivity?A Verri, A Montecucco, G Gosselin, et al.
Toxicologic Pathology|January 1, 1987
Alteration of DNA tertiary structure by physical and chemical carcinogens: involvement in DNA repair processesS Spadari, B M Sutherland, G Pedrali-Noy, et al.
Antiviral Research|May 1, 1996
9-(4-Hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in miceB M Gebhardt, G E Wright, H Xu, et al.
Journal of Medicinal Chemistry|January 6, 1995
Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinasesH Xu, G Maga, F Focher, et al.
Nucleosides & Nucleotides|August 5, 1999
Synthesis and molecular modeling of novel HSV1 uracil-DNA glycosylase inhibitorsM Pregnolato, D Ubiali, A Verri, et al.
Molecular Pharmacology|January 1, 1997
Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agentsA Verri, F Focher, G Priori, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Arzneimittel-Forschung|January 1, 1985
Control of cell division by aphidicolin without adverse effects upon resting cellsS Spadari, F Focher, F Sala, et al.
Parasitology|April 17, 2009
Thymidine kinase and uridine-cytidine kinase from Entamoeba histolytica: cloning, characterization, and search for specific inhibitorsA Lossani, A Torti, S Gatti, et al.
The Biochemical Journal|January 23, 1999
L-ATP is recognized by some cellular and viral enzymes: does chance drive enzymic enantioselectivity?A Verri, A Montecucco, G Gosselin, et al.
Journal of Medicinal Chemistry|July 13, 2000
Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesisF Focher, D Ubiali, M Pregnolato, et al.
Nucleosides & Nucleotides|August 5, 1999
Interaction of beta-L-adenosine-5'-triphosphate (L-ATP) with human deoxycytidine kinase, human DNA primase and T4 DNA ligase: does the chance direct enzymatic enantioselectivity?A Verri, A Montecucco, G Gosselin, et al.
Toxicologic Pathology|January 1, 1987
Alteration of DNA tertiary structure by physical and chemical carcinogens: involvement in DNA repair processesS Spadari, B M Sutherland, G Pedrali-Noy, et al.
Antiviral Research|May 1, 1996
9-(4-Hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in miceB M Gebhardt, G E Wright, H Xu, et al.
Journal of Medicinal Chemistry|January 6, 1995
Synthesis, properties, and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinasesH Xu, G Maga, F Focher, et al.
Nucleosides & Nucleotides|August 5, 1999
Synthesis and molecular modeling of novel HSV1 uracil-DNA glycosylase inhibitorsM Pregnolato, D Ubiali, A Verri, et al.
Molecular Pharmacology|January 1, 1997
Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agentsA Verri, F Focher, G Priori, et al.
Pageof 7